CREDIT SUISSE AG/ - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 58 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$1,114,0000.0%900,0000.0%0.00%0.0%
Q4 2021$1,114,000
+47.5%
900,000
+50.0%
0.00%
Q3 2021$755,000
-5.3%
600,0000.0%0.00%
Q2 2021$797,000
-1.2%
600,0000.0%0.00%
Q1 2021$807,000
+94.9%
600,000
+100.0%
0.00%
Q4 2020$414,000
+0.2%
300,0000.0%0.00%
Q3 2020$413,000
-63.0%
300,000
-55.4%
0.00%
-100.0%
Q2 2020$1,117,000
+86.8%
672,000
+43.9%
0.00%0.0%
Q1 2020$598,000
-16.4%
467,0000.0%0.00%0.0%
Q4 2019$715,000
-55.6%
467,000
-60.3%
0.00%0.0%
Q3 2019$1,609,000
-26.8%
1,175,000
-29.9%
0.00%
-50.0%
Q2 2019$2,198,000
+14.5%
1,675,000
+18.0%
0.00%0.0%
Q1 2019$1,919,000
+436.0%
1,420,000
+373.3%
0.00%
Q4 2018$358,000
-73.7%
300,000
-62.5%
0.00%
-100.0%
Q3 2018$1,363,000
-46.0%
800,000
-54.3%
0.00%
-50.0%
Q2 2018$2,526,0001,750,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2019
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders